The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset

The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset

Background and purpose: Proton therapy is expected to outperform photon-based treatment regarding organs at risk (OAR) sparing but to date there is no method to practically measure clinical benefit. Here, we introduce the novel ROCOCO Performance Scoring System (RPSS) translating dose differences in...

Full description

Bibliographic Details
Main Authors: Lieke in 't Ven, Erik Roelofs, Macarena Cubillos Mesías, Inge Compter, Yvonne L.B. Klaver, Robert Jan Smeenk, Geert O. Janssens, Johannes H.A.M. Kaanders, Raquel Davila Fajardo, Foppe Oldenburger, Dirk de Ruysscher, Esther G.C. Troost, Daniëlle B.P. Eekers
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Low grade glioma
Pilocytic astrocytoma
Organ at risk
Proton therapy
Cognition
Scoring system
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630821000203

Internet

http://www.sciencedirect.com/science/article/pii/S2405630821000203

Similar Items